13F Holdings
中文EN

Omega Fund Management, LLC

Boston MA · SEC CIK 0001637359

2026Q22026Q1 9 earlier quarters 🔒
$185.69M2026Q2 reported value
10Positions
100.0%Top 10 weight · largest 29.1%
0 / 1New / sold out
Reported value over time$185.69M2026Q2
26Q126Q2

All 11 quarters on paid plans 🔒

Top 10 holdings % of portfolio

BCAX 29.1%
NUVB 24.7%
KMTS 14.0%
BBOT 13.5%
BBNX 11.1%
ALMS 3.7%
SANA 1.6%
ImageneBio, In 1.4%
enGene Holding 0.8%
ODTX 0.0%

2026Q2 top buys estimated at quarter-end value

No buys this quarter

2026Q2 top sells estimated at quarter-end value

BCAX Reduced-$16.92M
REPL Sold out-$1.91M

2026Q2 holdings click a header to sort

Export CSV 🔒
TickerNameValue ▼WeightSharesShare changeChangeEst. flowAction
BCAX Bicara Therapeutics Inc. $54.10M29.14%1,822,150 -570,000-23.8% -$16.92M Reduced
NUVB Nuvation Bio Inc. $45.90M24.72%8,081,089 00.0% — Unchanged
KMTS Kestra Med Technologies Ltd $26.00M14.00%1,022,149 00.0% — Unchanged
BBOT BridgeBio Oncology Therapeutics Inc. $25.07M13.50%3,289,661 00.0% — Unchanged
BBNX Beta Bionics Inc. $20.62M11.11%1,316,183 00.0% — Unchanged
ALMS Alumis Inc. $6.79M3.66%241,255 00.0% — Unchanged
SANA Sana Biotechnology, Inc. $2.94M1.59%843,750 00.0% — Unchanged
— ImageneBio, Inc. $2.69M1.45%455,361 00.0% — Unchanged
— enGene Holdings Inc. $1.52M0.82%876,357 00.0% — Reappeared
ODTX Odyssey Therapeutics Inc. $54,1280.03%2,893 2,893— — First reported
REPL Replimune Group $00.00%0 -248,672-100.0% -$1.91M Sold out